H. Kwiecinski

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Hubert Kwiecinski, H. Kwiecinski, Hubert Kwieciński, H. Kwieciñski, H Kwiecinski, H Kwieciński, H. Kwieciński
Publication record
151 papers · 5,484 citations · H-index 31

PAPERS

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
2019170 citationsauthor #144
WITHDRAWN: Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients.
20180 citationsauthor #12
Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients.
20182 citationsauthor #12
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
2017260 citationsauthor #460
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS
201698 citationsauthor #321
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS
201698 citationsauthor #12
Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G>A de novo mutation—a 5 year follow up
20140 citationsauthor #9
Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G>A de novo mutation—a 5 year follow up
20149 citationsauthor #10
Mitochondrial encephalomyopathy: towards diagnosis. A case report.
20141 citationsauthor #8
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
20148 citationsauthor #5
NMR-based Metabonomics of Cerebrospinal Fluid Applied to Amyotrophic Lateral Sclerosis
201312 citationsauthor #4
Analysis of PITX3 gene in patients with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration.
20131 citationsauthor #8
A case report of 'variant' biochemical phenotype of Niemann-Pick C disease and a discussion of therapeutic options.
20135 citationsauthor #7
ALS Untangled No. 20: The Deanna Protocol
201321 citationsauthor #26
Recurrent K3E mutation in Cu/Zn superoxide dismutase gene associated with amyotrophic lateral sclerosis
20138 citationsauthor #12
Recurrent G41S mutation in Cu/Zn superoxide dismutase gene (SOD1) causing familial amyotrophic lateral sclerosis in a large Polish family
20125 citationsauthor #11
A single-fibre electromyography study of neuromuscular transmission in patients with cluster headache.
20121 citationsauthor #5
ALSUntangled 15: Coconut Oil
20126 citationsauthor #19
ALS Untangled No. 17: “When ALS Is Lyme”
20125 citationsauthor #25
[Psychotic symptoms and cognitive impairment in neurosarcoidosis. Case report and review of literature].
20121 citationsauthor #7
Erratum: Recurrent G41S mutation in Cu/Zn superoxide dismutase gene (SOD1) causing familial amyotrophic lateral sclerosis in a large Polish family (Amyotrophic Lateral Sclerosis (2012) 13 (132-136))
20120 citationsauthor #11
Mitochondrial encephalopathy in a patient with a 13042G>A de novo mutation
20123 citationsauthor #9
ALSUntangled No. 16: Cannabis
20128 citationsauthor #19
New therapeutic targets for amyotrophic lateral sclerosis
201125 citationsauthor #2
[Expert opinion on use of intravenous immunoglobulins in the management of neurological disorders].
20110 citationsauthor #9
Recommendations for the Diagnosis and Management of Spontaneous Intracerebral Haemorrhage
20110 citationsauthor #5
Extraction of biomedical traits for patients with Amyotrophic Lateral Sclerosis using parallel and hierarchical classifiers
20116 citationsauthor #5
Gene therapy of amyotrophic lateral sclerosis
20110 citationsauthor #2
Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
2011198 citationsauthor #145
NMDA receptor gene variations as modifiers in Huntington disease: a replication study
201123 citationsauthor #175
Temporal training improves both auditory comprehension and speech production in aphasic patients
20110 citationsauthor #7
Professor Kazimierz Orzechowski - initiator of the first university department of neurology in Warsaw.
20110 citationsauthor #2
Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
201120 citationsauthor #6
Efficacy and safety of natalizumab re-dosing and treatment in patients from Poland
20110 citationsauthor #6
Sclerosis lateralis amyotrophica.
20100 citationsauthor #2
Recent advances in the diagnosis and therapy of neurological diseases
20100 citationsauthor #1
Polymorphisms in the factor VII gene and ischemic stroke in young adults
201021 citationsauthor #6
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
201086 citationsauthor #4
Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family.
20109 citationsauthor #5
Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients
201029 citationsauthor #4
The analysis of selected neurotransmitter concentrations in serum of patients with Tourette syndrome.
201015 citationsauthor #5
Diffusion-Tensor Imaging of Corticospinal Tracts in Patients with Amyotrophic Lateral Sclerosis
20101 citationsauthor #7
Neurology training around the world: asking the trainees.
20103 citationsauthor #8
Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy
200931 citationsauthor #2
[Intravenous thrombolysis in the treatment of acute ischaemic stroke: 3, 4.5, or 6 hours?].
20092 citationsauthor #1
Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
20097 citationsauthor #7
Mitochondrial cytopathies: clinical, morphological and genetic characteristics.
200910 citationsauthor #7
ANALYSIS OF MATRIX METALLOPROTEINASES (MMPS) IN CEREBROSPINAL FLUID OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)
20092 citationsauthor #5
The genetics of amyotrophic lateral sclerosis.
20096 citationsauthor #2
Adam Opalski (1897–1963)
20091 citationsauthor #2
Pattern recognition approach to differentiation of disease severity in patients with amyotrophic lateral sclerosis
20083 citationsauthor #5
[CADASIL syndrome - cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy].
20083 citationsauthor #2
MuSK‐positive myasthenia gravis is rare in the Polish population
200832 citationsauthor #7
Paroxysmal Non-Kinesigenic Dyskinesia Caused by the Mutation of MR-1 in a Large Polish Kindred
200811 citationsauthor #6
Myotonic syndromes: one gene – different phenotypes
20080 citationsauthor #3
[Neurological disorders in patients with obstructive sleep apnea (OSA)].
20070 citationsauthor #2
Multi-minicore myopathy: a clinical and histopathological study of 17 cases.
20071 citationsauthor #6
Genotype–phenotype correlation of paroxysmal nonkinesigenic dyskinesia
2007141 citationsauthor #14
Ischaemic stroke in patients with patent foramen ovale.
20072 citationsauthor #2
Elevated levels of anti‐Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke
200724 citationsauthor #5
Possible role of rethymectomy for nonthymomatous myasthenia gravis
20070 citationsauthor #7
Amyotrophic lateral sclerosis:how far away are we from the Charcot description?
20060 citationsauthor #1
APOE epsilon variation in multiple sclerosis susceptibility and disease severity
200692 citationsauthor #31
DEBATE Ischaemic stroke in a patient with patent foramen ovale (PFO): secondary preventionNeurologist’s statepointHubert Kwieciński
20060 citationsauthor #1
Frequency of a tau genotype in amyotrophic lateral sclerosis.
200512 citationsauthor #7
A single-fibre EMG Study of Neuromuscular Transmission in Migraine Patients
200525 citationsauthor #3
Comment to article Evaluation of cerebral circulation in patients with significant carotid artery stenosis
20050 citationsauthor #1
[Is migraine a neuronal channelopothy?].
20051 citationsauthor #1
ENS News
20041 citationsauthor #3
Tubulovesicular structures in Creutzfeldt-Jakob disease
200420 citationsauthor #5
CADASIL or CADVaSIL?
200424 citationsauthor #6
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway.
2004175 citationsauthor #7
Correlating phenotype and genotype in the periodic paralyses
2004257 citationsauthor #4
Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy
200460 citationsauthor #11
Fifth Meeting of the European Neurological Society
20040 citationsauthor #9
[The prevalence of patent foramen ovale in patients with migraine].
200428 citationsauthor #3
Improvement of motor function in early Parkinson disease by safinamide
2004101 citationsauthor #4
Prevention. European Stroke Initiative.
200452 citationsauthor #2
Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
200465 citationsauthor #3
Treatment of myotonic dystrophy with acetazolamide
20044 citationsauthor #1
Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
20044 citationsauthor #3
Mutations and polymorphisms of the CLCN2 gene in idiopathic epilepsy
200469 citationsauthor #9
Serum IgM anti‐GM1 ganglioside antibodies in lower motor neuron syndromes
200427 citationsauthor #3
Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis
200458 citationsauthor #7
[Hashimoto's encephalopathy. Case report and literature review].
20041 citationsauthor #4
Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
200435 citationsauthor #10
Neurology training around the world.
200314 citationsauthor #6
Prevention
20030 citationsauthor #2
[Open trial of the effectiveness of interferon beta 1a (Avonex) in multiple sclerosis. Clinical assessment using motor coordination tests].
20030 citationsauthor #3
Percutaneous internal carotid artery angioplasty with stenting: early and long-term results.
20039 citationsauthor #4
[Open trial of the effectiveness of interferon beta 1a (Avonex) in the treatment of multiple sclerosis in Poland: MRI results].
20031 citationsauthor #5
CADASIL: new cases and new questions
200318 citationsauthor #6
[Leber's hereditary optic neuropathy (LHON) with mutation at G3460A and MS-like phenotype].
20035 citationsauthor #6
Protein Z in Young Survivors of Ischemic Stroke
200248 citationsauthor #3
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
2002545 citationsauthor #8
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
2002975 citationsauthor #4
Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis
200222 citationsauthor #3
[The role of mitochondrial respiratory chain in the pathogenesis of ALS].
20010 citationsauthor #3
[Symptomatic treatment and palliative care of ALS].
200116 citationsauthor #1
[Kennedy's disease: expansion of the CAG trinucleotide].
20013 citationsauthor #5

TIMELINE

1974 13 citations

1975 6 citations

1976 7 citations

1978 9 citations

1981 27 citations

1983 5 citations

1984 69 citations

1987 1 citations

1988 3 citations

1990 0 citations

1991 3 citations

1992 110 citations

1993 127 citations

1994 435 citations

1995 46 citations

1996 103 citations

1997 0 citations

1998 66 citations

1999 137 citations

2000 40 citations

2001 101 citations

2002 1,590 citations

2003 47 citations

2004 981 citations

2005 38 citations

2006 92 citations

2007 168 citations

2008 49 citations

2009 59 citations

2010 164 citations

2011 272 citations

2012 29 citations

2013 47 citations

2014 18 citations

2016 98 citations

2017 260 citations

2018 2 citations

2019 170 citations

H. Kwiecinski

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT